Etoricoxib
Etoricoxib is a pharmaceutical drug with 46 clinical trials. Currently 1 active trials ongoing. Historical success rate of 94.3%.
Success Metrics
Based on 33 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
8
Mid Stage
26
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.8%
33 of 38 finished
13.2%
5 ended early
1
trials recruiting
46
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Etoricoxib in Patients With Parkinsonian Disease
Immediate Analgesic Effects of Cheek Acupuncture for Acute Gouty Arthritis
Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082)
Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic
Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163)
Clinical Trials (46)
Etoricoxib in Patients With Parkinsonian Disease
Immediate Analgesic Effects of Cheek Acupuncture for Acute Gouty Arthritis
Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082)
Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic
Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163)
Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)
A Study of Etoricoxib in Participants With Osteoarthritis Not Responding to Analgesic Drugs (MK-0663-142)
Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib
Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)
Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1)
Study of the Bioequivalence of the 20% and 30% Etoricoxib Tablet Formulations (0663-070)
Patient-Reported Effectiveness and Safety of Etoricoxib in Osteoarthritis (OA)(0663-113)
Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA)
Rebound Pain After Operations for Distal Radius Fractures With a Volar Plate in Brachial Plexus Block
Oral Huzhang Granules for Acute Gouty Arthritis
Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid Arthritis
A Study Comparing Etoricoxib and Diclofenac Sodium in Post Hallux Valgus Surgery Pain
Outcomes Of Perioperative Pregabalin On Total Knee Arthroplasty
Effect of an Anti-inflammatory on Tooth Sensitivity Caused by Bleaching
Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected Patients
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 46